RXRX - RECURSION PHARMACEUTICALS, INC.

QQQ $ 450.22 $ 2.34 (0.52 %)

DIA $ 395.16 $ 0.63 (0.16 %)

SPY $ 532.81 $ 2.34 (0.44 %)

TLT $ 96.28 $ 0.94 (0.99 %)

GLD $ 224.54 $ 0.55 (0.25 %)

Previous Close

$ 6.29

Open

Bid

$ 6.28 x 900

Ask

$ 6.30 x 1,300

Day's Range

-- - --

52 Week Range

$ 4.97 - $ 15.74

Volume

8,675,382

Average Volume

Market Cap

1.52B

Beta (5Y Monthly)

$ 2.28

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-29-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	02-27-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-23-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-13-2021	06-30-2021	10-Q
14	05-12-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Maintains Buy on Recursion Pharmac...
08/09/2024 11:57:32

Needham analyst Gil Blum maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and lowers the price target from $17 t...

ai-powered-drug-discovery-firm-exscientia-to-merge-with-nvidia-partner-recursion-pharmaceuticals

AI-Powered Drug Discovery Firm Exscientia ...
08/08/2024 21:37:28

Exscientia merges with Recursion Pharmaceuticals in an all-stock deal. The new entity, named Recursion, will focus on industria...

Recursion And Exscientia Announce Definiti...
08/08/2024 11:40:39

Expect 10 Clinical Readouts In 18 Months, $200M In Milestone Payments Over 24 Months, $20B Potentially Overall, $850M Cash On H...

bank-of-new-york-mellon-posts-upbeat-earnings-joins-archer-aviation-rivian-automotive-and-other-big-stocks-moving-higher-on-friday

Bank of New York Mellon Posts Upbeat Earni...
07/12/2024 14:27:17

Keybanc Maintains Overweight on Recursion ...
07/11/2024 11:01:31

Keybanc analyst Scott Schoenhaus maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Overweight and lowers the price ta...

cathie-woods-ark-invest-sells-tesla-shares-worth-145m-amid-rally-driven-by-q2-delivery-numbers-picks-up-palantir-shares-again-today

Cathie Wood's Ark Invest Sells Tesla Share...
07/03/2024 02:26:04

cathie-wood-led-ark-invest-scoops-up-516m-worth-of-palantir-shares-amid-raging-ai-fervor

Cathie Wood-Led Ark Invest Scoops Up $5.16...
07/02/2024 02:19:31

why-recursion-pharmaceuticals-stock-is-tumbling-thursday

Why Recursion Pharmaceuticals Stock Is Tum...
06/27/2024 13:19:50

Recursion announced that it intends to offer and sell 30,769,230 shares of its common stock for $6.50 per share in an underwri...

Market-Moving News for June 27th
06/27/2024 12:37:40

CASI: 92% | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Prop...

levi-strauss-posts-mixed-results-joins-walgreens-aerovironment-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

Levi Strauss Posts Mixed Results, Joins Wa...
06/27/2024 12:33:51

Recursion Pharmaceuticals Announced The Pr...
06/27/2024 07:10:10

recursion-pharmaceuticals-stock-is-diving-wednesday-whats-going-on

Recursion Pharmaceuticals Stock Is Diving ...
06/26/2024 21:00:52

After the market close on Wednesday, Recursion said it intends to offer and sell $200 million worth of its common stock in an u...

Recursion Announces Proposed Offering Of $...
06/26/2024 20:07:10

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
06/26/2024 17:35:22

10 Health Care Stocks Whale Activity In To...
06/25/2024 17:35:24

recursion-pharmaceuticals-stock-is-moving-tuesday-whats-happening

Recursion Pharmaceuticals Stock Is Moving ...
06/25/2024 13:23:24

Shares of clinical stage biotech company Recursion Pharmaceuticals Inc (NASDAQ:RXRX) are trading higher Tuesday. The company...

Needham Reiterates Buy on Recursion Pharma...
06/25/2024 11:45:18

Needham analyst Gil Blum reiterates Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and maintains $17 price target.

whats-going-on-with-recursion-pharmaceuticals-stock-monday

What's Going On With Recursion Pharmaceuti...
06/24/2024 21:12:29

Recursion Pharmaceuticals shares traded higher Monday after the company provided updated guidance and partnership updates at it...

10 Health Care Stocks Whale Activity In To...
06/24/2024 17:35:23

Helix, Recursion Pharmaceuticals Partner T...
06/24/2024 13:03:23

Access to Helix's large-scale clinico-genomic data to drive creation and training of AI modelsHelix, a leading population g...